FDA clears Dexcom Stelo as the first OTC CGM for children, raising new questions around app access, caregiver oversight, school device rules, and reimbursement.

In March 2024, the FDA approved the first over-the-counter continuous glucose monitors (CGMs), marking a quiet but significant shift in how we can track and understand our health. Devices like ...

DXCM's redesigned Stelo app is set for a July U.S. rollout, with international expansion and pediatric clearance broadening ...

Wearable glucose trackers have moved from the pharmacy counter to the checkout aisle, and the OTC CGM comparison shoppers are now making at home looks a lot like the one diabetes patients used to ...

Over-the-counter continuous glucose monitors have moved from a diabetes-only tool into the broader metabolic health conversation, and shoppers now face a real decision. Here is an OTC CGM comparison ...